Long-term potentiation (LTP), a long-lasting enhancement in communication between neurons, is considered to be the major cellular mechanism underlying learning and memory. LTP triggers high-frequency calcium pulses that result in the activation of Calcium/Calmodulin (CaM)-dependent kinase II (CaMKII). CaMKII acts as a molecular switch because it remains active for a long time after the return to basal calcium levels, which is a unique property required for CaMKII function. Here we describe the crystal structure of the human CaMKIId/Ca 2+ /CaM complex, structures of all four human CaMKII catalytic domains in their autoinhibited states, as well as structures of human CaMKII oligomerization domains in their tetradecameric and physiological dodecameric states. All four autoinhibited human CaMKIIs were monomeric in the determined crystal structures but associated weakly in solution. In the CaMKIId/Ca 2+ /CaM complex, the inhibitory region adopted an extended conformation and interacted with an adjacent catalytic domain positioning T287 into the active site of the interacting protomer. Comparisons with autoinhibited CaMKII structures showed that binding of calmodulin leads to the rearrangement of residues in the active site to a conformation suitable for ATP binding and to the closure of the binding groove for the autoinhibitory helix by helix aD. The structural data, together with biophysical interaction studies, reveals the mechanism of CaMKII activation by calmodulin and explains many of the unique regulatory properties of these two essential signaling molecules.
Introduction
Calcium/Calmodulin (Ca 2+ /CaM)-dependent serine/threonine kinases (CaMKs) constitute a family of 81 proteins in the human proteome that play a central role in cellular signaling by transmitting Ca 2+ signals [1] . Kinases in this protein family are activated through binding of Ca 2+ /CaM to regulatory regions that either flank the catalytic domain or are located in regulatory molecules [2] . Four CaMKII isozymes (a, b, c, and d), in addition to about 30 splice variants, are expressed in humans. The a and b isoforms are brain specific and together make up approximately 1% of total brain protein in rodents and up to 2% of total protein in their hippocampus [3] . The c and d isoforms are expressed in most tissues, but in comparison have much lower expression levels [4, 5] . The unique switch-like properties of CaMKII activation and its extremely high abundance in the brain identified CaMKII as a key regulator of cellular memory and learning [6] . CaMKII is essential for the induction of long-term potentiation (LTP), a longlasting increase in the efficiency of synaptic transmission between neurons that is believed to be a cellular correlate of memory [7, 8] . Stimuli that induce LTP lead to autophosphorylation at T286 in CaMKIIa (T287 in the b, c, and d isoforms), thereby resulting in sustained CaMKII activation [9] ; mice expressing the CaMKIIa T286A mutant were severely impaired in learning [10] .
Several CaMKIId variants are highly abundant in myocardial tissue [11, 12] . Increased CaMKII activity has been observed in patients with structural heart disease and arrhythmias, where prolonged action potential duration leads to sustained hyperactivation of CaMKII and heart failure [11] .
CaMKII proteins form large oligomeric structures. The Nterminal kinase domain is tethered via an autoinhibitory helix and a calmodulin binding site to a C-terminal oligomerization domain that organizes the enzyme into ring-shaped oligomers. Three-dimensional reconstruction of single-particle electron microscopy images revealed dodecameric assemblies for all purified homogeneous fulllength CaMKII isozymes [13, 14] . In contrast, tetradecamers were detected in the crystal structures of isolated oligomerization domains. This non-physiological oligomerization state has been attributed to the absence of the kinase domain [15, 16] .
The cellular regulation of CaMKII activity is the outcome of a complex interplay between protein localization, heterooligomerization, local Ca 2+ /CaM concentrations, CaMKII autophosphorylation, and dephosphorylation of CaMKII by phosphatases [2, 17] . The structure of the isolated Caenorhabditis elegans CaMKII (CeCaMKII) kinase domain in its autoinhibited state provided the first insight into the molecular mechanism of CaMKII regulation [18] . In this structure the inhibitory domain forms a helix that binds tightly to the substrate binding pocket preventing access of substrates. Interestingly, the regulatory domains of two catalytic domains interacted as antiparallel coiled-coils in the CeCaMKII structure suggesting that the inhibitory helix mediates self association in the inactive state of the enzyme. This association model has also been evoked to explain cooperativity of CaMKII activation by Ca 2+ /CaM observed in enzyme kinetic assays and ''pairing'' of kinase domains in autoinhibited holoenzymes [19, 20] . In the inactive state the autophosphorylation site within the regulatory domains is not accessible [18] . It has been speculated that this inhibitory ''block'' of the regulatory domain is released by structural changes induced upon Ca 2+ /CaM binding. Once phosphorylated at the regulatory T286 site (CaMKIIa numbering) by catalytic domains present in the same holoenzyme, steric constraints prevent rebinding of the autoinhibitory domain to the catalytic domain [4, 21, 22] .
In addition, CaMKII can be made insensitive to Ca 2+ /CaM by autophosphorylation at T305/T306 located within the Ca 2+ /CaM binding site [23, 24] , a process that is facilitated by interaction with the membrane associated guanylate kinase (MAGUK/CASK) [25, 26] . The balance between the Ca 2+ /CaM-sensitive and -insensitive CaMKII pool is critical for the regulation of postsynaptic plasticity [27, 28] .
In CaMKIIa, autophosphorylation of T306 but not of T305 was observed in vitro, leading to a strong reduction of Ca 2+ /CaM binding [29] . The region flanking this autophosphorylation site represents a non-consensus substrate site for CaMKII, which raises the question of how this motif would be efficiently recognized as a substrate.
To date, our structural knowledge of how CaMKIIs are activated is based solely on structures of isolated kinase domains and peptide complexes of either catalytic domains with their substrates or Ca 2+ / CaM with calmodulin binding sites [18, 20] . We were interested in describing the molecular mechanisms that govern CaMKII activation in an intact catalytic domain/Ca 2+ /CaM complex. The structure of the CaMKIId/Ca 2+ /CaM presented here captures the kinase in a state where the inhibitory helix is dislodged from the substrate binding site, thereby making it available for autophosphorylation by an adjacent kinase molecule. Analysis of this co-crystal structure, structures of all human isozymes in their autoinhibited state, and in-solution association studies showed that binding of Ca 2+ /CaM triggers large structural changes in the kinase domain as well as in the CaMKII regulatory domain that together lead to allosteric kinase activation. Furthermore, we also describe the structure of an oligomerization domain in its physiological, dodecameric state. Based on the comparison of this large body of structural information and biochemical characterization we propose a model that explains the substrate recognition leading to Ca 2+ / CaM-dependent allosteric activation of human CaMKIIs.
Results

Structures of Autoinhibited Human CaMKII Isozymes
To date, our understanding of the molecular mechanisms that define the CaMKII autoinhibited state are based on the structural model of the C. elegans CaMKII orthologue (CeCaMKII). This crystal structure shows an occluded substrate binding site, rearrangements in the ATP binding site that disturb co-factor binding and a remarkable dimeric assembly involving the inhibitory helix and the CaM binding motif (corresponding to residues K293-F313 in CaMKIIa) [18] . CeCaMKII and human CaMKIIa share 77% sequence identity. We were interested in determining whether regulatory mechanisms suggested based on the crystal structure of CeCaMKII would be conserved in human CaMKII isozymes. To address this, we determined the structures of all human CaMKII isozymes in their autoinhibited state. The structures were refined at resolutions ranging from 2.25 Å (CaMKIIc) to 2.4 Å (CaMKIIb). Details of the diffraction data statistics and refinement have been summarized in Table S1 . Importantly, whereas the crystallized constructs of the a and b isozymes contained the catalytic domain and the inhibitory region but only a part of the Ca 2+ /CaM binding motif, the constructs of both CaMKIIc and CaMKIId additionally contained the entire regulatory region as well as a part of the unstructured linker to the association domain. The boundaries used for the crystallized proteins are shown in the boxed sequence inserts in Figure 1A and are indicated in the sequence alignment in Figure S1 . As expected, based on the high sequence homology, all structures exhibited a high degree of structural similarity. The activation segments were all well-ordered and helix aC was correctly positioned for catalysis as indicated by formation of the conserved salt bridge between E60 located in aC and lysine K41, which is a hallmark of the active kinase conformation [30] (Figure S2 ).
Similar to the C. elegans orthologue, the substrate binding site is blocked by the regulatory domain in all human CaMKIIs ( Figure 1B) /CaM, as well as the structure of the oligomerization domain (the part of the protein that mediates complex formation) in its physiological dodecameric state and in a tetradecameric state. Detailed comparison of this large body of structural data together with biophysical studies has allowed us to better understand the structural mechanisms of CaMKII activation by CaM and to explain many of the complex regulatory features of these essential enzymes.
regulatory domain, was not observed for any of the autoinhibited human isozymes. As mentioned above, the C termini of the crystallized c and d isozymes extended well beyond the Ca 2+ /CaM binding site (in CaMKIId, including the linker region up to S333). However, the autoinhibitory helices in all isozymes were structured only up to residue 302. Different crystal forms were observed, containing one (CaMKIIc), two (CaMKIIa and CaMKIId), or four molecules (CaMKIIb) in the asymmetric unit. However, no indication of a conserved dimer interface was evident within the crystals with packing contact regions typically involving small and diverse surface areas. However, evidence that dimerization occurs in solution was found using analytical ultracentrifugation (AUC) sedimentation velocity experiments for all CaMKII catalytic domains (exemplified by CaMKIId in Figure 1C ), thus supporting studies that identified inactive CaMKII as paired (dimers) in cells [19] . The affinities, as estimated from the proportions between the areas of the peaks for monomeric and dimeric species, were weak (K D of 200-600 mM), but due to the high effective concentrations of catalytic domains in the context of the holoenzyme, the observed interactions are likely to be biologically relevant (Table S2 ). Similar association constants were observed for all human CaMKIIs independent of the construct length, suggesting that dimerization is not mediated by the regulatory domain in human CaMKIIs. To test this hypothesis, we repeated the AUC experiments in the presence of an isolated regulatory domain peptide that spans the autoinhibitory region as well as the Ca Interestingly, no change in the proportion between the peaks was observed (red trace in Figure 1C ), suggesting that binding of the peptide did not interfere with dimerization in human CaMKIIs. Binding of the peptide led to a significant shift towards smaller sedimentation coefficients, suggesting that interaction with the peptide induces a conformational change that leads to increased friction. Based on these data, it is tempting to speculate that binding of the peptide displaces and subsequently causes unfolding of the inhibitory helix and the Ca 2+ /CaM binding site, as observed in the structure of the Ca 2+ /CaM complex.
Structural Reorganization of the Catalytic and Inhibitory Domains Induced by Ca 2+ /CaM Binding
We were interested in exploring the structural consequences of Ca 2+ /CaM binding on CaMKII and determined the structure of the CaMKIId/Ca 2+ /CaM complex ( Figure 2B ). The structure of the complex comprised the catalytic and the regulatory domain of CaMKII (residues 1-333) and full length human calmodulin, and was refined at 1.9 Å resolution to an R/R free of 16.1 and 19.9%, respectively (Table S1 ). In the complex, the regulatory region no longer interacted with its corresponding catalytic domain ( Figure 2B ). Instead, the conformation of the inhibitory region adopted an extended conformation, in sharp contrast to its helical secondary structure in autoinhibited CaMKII ( Figure 2A ). The observed extended conformation allowed interaction between the inhibitory region and the substrate binding site of an adjacent catalytic domain. Most notably, T287 was aligned in a position suitable for phosphoryl transfer ( Figure 2B ). Thus, the structure effectively ''captures'' CaMKIId in the process of transphosphorylation by a neighboring kinase molecule. The Ca 2+ /CaM binding region exhibits equally significant structural changes compared to the autoinhibited kinase. Although this region displays either an extended or partially disordered conformation in all human autoinhibited CaMKIIs, it adopts an entirely helical secondary structure in the Ca 2+ /CaM complex ( Figure 2C ). The CaMKIId/Ca 2+ /CaM co-crystal structure revealed that phosphorylation at T287 is not the only mechanism that prevents the regulatory region from rebinding to the lower kinase lobe. In the complex, helix aD blocked the access to the binding site for the inhibitory helix by a significant reorientation of this helix with respect to the autoinhibited kinase; E106 and Y107, for instance, are displaced by more than 10 Å from their position (Ca) in the autoinhibited kinase and block the binding groove for the inhibitory helix ( Figure 2D ). The movement of aD has another important consequence which results in structural changes within the kinase active site: E97, which is oriented away from the ATP binding site in autoinhibited CaMKIIs, was positioned in a conformation that enables coordination of the ATP co-factor in the CaMKIId/Ca 2+ /CaM complex. This transition has been proposed previously based on in silico molecular dynamics simulations using the autoinhibited CeCaMKII structure in which the regulatory region was deleted [18] . It is well known that the affinity of CaMKII for ATP is significantly reduced in the absence of Ca 2+ /CaM [29, 31, [32] [33] [34] . E97 is highly conserved in kinases and plays a major role in recruiting ATP by forming interactions with the sugar moiety [35] . Similar conformations involving altered orientations of E97 that lead to kinase inactivation have been observed in autoinhibited structures of CaMK1 [36] and twitchin [37] , suggesting that reorientation of aD is a common regulatory mechanism in CaMKs. An animation that illustrates the conformational changes that take place during Ca 2+ /CaMdependent CaMKII activation has been embedded in the enhanced version of the manuscript (Datapack S1).
Substrate Recognition of the T287 Phosphorylation Site
Transphosphorylation of T287 (T286 in CaMKIIa) by a catalytic domain present in the same holoenzyme has been described as the molecular switch that leads to constitutive and Ca 2+ /CaMindependent CaMKII activity [4, 21, 22] . The sequence flanking T287 represents a typical CaMK consensus substrate site [38] . The structure of the CaMKIId/Ca 2+ /CaM complex revealed how the regulatory region flanking T287 is recognized as a substrate: The arginine residue in position 23 (R284)-a hallmark of CaMK substrate recognition-exhibits two conformations and forms multiple polar interactions with the aD residues E100 and E97 ( Figure 3A) . The conformations of residues interacting within the substrate binding site were well defined in the electron density ( Figure 3B ). The structure of this substrate complex is similar to a CeCaMKII/peptide complex published recently [20] .
We used analytical ultracentrifugation (AUC) to determine whether the CaMKII/Ca 2+ /CaM heterodimer forms in solution and to estimate affinities for the T287-substrate interaction. In agreement with our structural data, sedimentation velocity experiments measured on the CaMKIId/Ca 2+ /CaM complex revealed apparent molecular weights that correspond well to the calculated mass of the complex. The experiments also revealed the presence of oligomers containing two or more copies of the CaMKII/Ca 2+ /CaM heterodimer ( Figure 3C ). We estimated dissociation constants (K D ) of 50 mM and 120 mM, for this selfassociation for the d and a isozymes, respectively (Table S2) . To further investigate whether the substrate binding pocket was indeed the interacting interface, we performed sedimentation velocity experiments in the presence of a substrate-competitive peptide. When a peptide derived from CaMKIId residues 282-310 was included, we observed only free Ca 2+ /CaM and the CaMKIId/Ca 2+ /CaM heterodimer in solution, but no higher association species. This experiment confirmed that the observed association is mediated by the substrate binding pocket recapitulating what was observed in the crystal structure of this complex.
Recognition of the CaMKIId T307 Autophosphorylation Site
In inactive synapses, slow autophosphorylation at T306 (T307 in CaMKIId) accumulates a CaMKII pool of subunits that cannot be activated by Ca 2+ /CaM and requires phosphatase activity for reactivation [39, 40] . The sequence flanking T307 represents a site that is incompatible with CaMKII consensus substrate requirements, raising the question as to how this regulatory phosphorylation site would be recognized as a kinase substrate. In the CaMKIId structure, T307 was bound to the substrate binding site and oriented in an identical fashion to that observed for T287 in the transphosphorylating complex. The T307-containing region adopts an unusual turn conformation not previously seen in kinase substrate complexes. This unusual binding mode was stabilized by hydrophobic interactions of the conserved residues I304 and L305 that bound inside a deep cavity formed by residues located in the P1 loop and in helix aG ( Figure 4A ). This hydrophobic anchor allows recognition of this non-consensus substrate site, thus providing insight into how T307 is recognized as a cis-autophosphorylation site.
Binding of Ca 2+ /CaM
Ca 2+ /CaM has the ability to bind to a large number of distinct proteins by adjusting the relative orientation of its EF hands [41] [42] [43] . Residues in the interface were well-defined and the recognition motif bound tightly within the central cavity of the Ca 2+ /CaM structure while no stable contacts were made with the kinase domain. The Ca 2+ /CaM interaction involved the CaMKII [29, 25] . Moreover, Ca 2+ / CaM binding to CaMKII with unphosphorylated T306 effectively prevents phosphorylation of this residue [26] . These data are in agreement with our co-crystal structure that showed that both threonine residues (T306/T307) were deeply buried within the Ca 2+ /CaM complex ( Figure 4B Figure 4C , Table 1 ). The determined binding affinities were in agreement with affinities determined for the full-length enzyme [33] . Ca 
Oligomeric Assembly of CaMKII
Oligomerization into large ring-like structures is a unique feature of CaMKIIs and the oligomeric state is crucial for rapid autophosphorylation in trans by catalytic domains present in the same oligomer [44] . The discrepancy between the dodecameric (12-mer) structures determined by electron microscopy [13, 14] and the tetradecameric (14-mer) assembly revealed by the crystal structure of the isolated oligomerization domain of the C. elegans orthologue [15] prompted us to crystallize the oligomerizaton domains of human CaMKII isozymes. Here we present the oligomerization domains of the human c and d isozymes that were refined at 2.7 and 2.8 Å resolution, respectively. The quality of the final model was substantially improved by averaging the electron density maps using non-crystallographic symmetry. While isolated domains of the d isozyme were tetradecameric, the CaMKIIc oligomerization domain crystallized in its dodecameric state, thus providing a model for the oligomerization state observed in fulllength CaMKIIs. The oligomerization domain formed a hexameric structure with a diameter of 120 Å and a height of 60 Å surrounding a central cavity of only 17 Å ( Figure 5A ). Thus, the main consequence of the insertion of an additional subunit per ring in the tetradecameric assembly is a considerable widening of the central cavity, to about 33 Å .
Each oligomerization domain in the ring also contains a deep cavity that has been suggested to represent a peptide binding site, based on structural homology with peptide-binding domains present in nuclear transport factors and scytalone dehydratase [15] . In support of this hypothesis is the fact that a glycine or an acetate molecule, respectively, originating from the crystallization solution were partially occupying this putative binding site in the structures of the CaMKIIc and CaMKIId oligomerization domains.
We used the structures of the dodecameric oligomerization domain, the CaMKIId/Ca 2+ /CaM complex and the structures of the inactive catalytic domains, to construct models for the fulllength enzyme ( Figure 5B ). In our model of the autoinhibited protein, catalytic domains located in both hexameric rings associate. The pairing was chosen arbitrarily whilst based on the orientation of the helices in the dodecameric oligomerization domain. Binding of Ca 2+ /CaM triggers unfolding of the inhibitory helix and releases the kinase domain. This structural reorganization allows T287 to bind to an adjacent kinase domain, leading to autophosphorylation and restructuring of the kinase domain to form a conformation with high affinity for ATP due to reorientation of aD. Once T287 has been phosphorylated, the kinase domain is released fully active and independent of Ca 2+ / CaM, and with its substrate binding site accessible.
Discussion
Four regulatory features distinguish the regulation of CaMKII isozymes from other CaMKs. Firstly, CaMKIIs form large oligomers bringing catalytic domains into close proximity to facilitate rapid autoactivation. Secondly, autophosphorylation of T287 generates Ca 2+ /CaM-independent sustained activity. Thirdly, phosphorylation of T287 increases the affinity of CaMKII for Ca 2+ /CaM by more than 10,000-fold, an effect known as CaM-trapping [45] . Fourthly, phosphorylation of T306/T307 leads to prevention of CaMKII activation, due to an interference with Ca 2+ /CaM binding. Comparison of the active CaMKII with its inactive autoinhibited structures provides a structural model for the unique switch-like mechanism of CaMKII autoactivation, as well as for its inactivation by autophosphorylation of T307. The different molecular mechanisms of CaMKII activation and inactivation are depicted in Figure 6 , and we discuss here the structural background of these regulatory events in the light of the determined structures.
Autophosphorylation of T307 and its neighbor T306 prevents binding of Ca 2+ /CaM, resulting in inhibitory autophosphorylation [44] . Moreover, knock-in mice expressing mutants of CaMKIIa incapable of phosphorylation of T306 (e.g. T306A, corresponding to T307 in CaMKIId) identified this residue as an important site regulating synaptic plasticity [46] . However, if T287 is phosphorylated prior to T307, Ca 2+ /CaM-independent activity is induced, whereas prior phosphorylation of T307 prevents activation and autophosphorylation of T287. This illustrates that the sequence of autophosphorylation events is a critical component of CaMKII regulation [47] . In agreement with the observation that ATP binding is impaired in autoinhibited CaMKII, we observed only slow autophosphor- ylation activity of CaMKIId in vitro minimizing premature phosphorylation of T307 (unpublished data). This phosphorylation is stimulated by interaction with CASK [25, 26] . Based on our model of inactive CaMKIIs, it is likely that binding of CASK leads to an allosteric rearrangement similar to the one observed upon release of the inhibitory helix that results in CaMKII activation and autophosphorylation of T306/T307 by the described non-canonical binding mode of the non-consensus substrate site at T307 in inactive CaMKIId.
A recent report showed that Angiotensin II-induced oxidation of the methionines M281/M282 leads to sustained activity of CaMKII in the absence of Ca 2+ /CaM, inducing apoptosis in cardiomyocytes [48] . The structure of inactive CaMKII suggests that oxidation of M282 would lead to steric clashes with the lower lobe, resulting in destabilization of the autoinhibited state and Ca 2+ /CaM-independent activation. In the CaMKIId/Ca 2+ /CaM complex, M282 binds into a tight hydrophobic pocket in the substrate binding site, suggesting that oxidation of this residue also interferes with substrate binding and autophosphorylation of T287 (see Figure 3A and 4A). Taken together, our structural data suggest that Met oxidation interferes with both the CaMKII inactive state and autophosphorylation of T287, thus supporting a role of M282 oxidation in CaMKII regulation [48] . The key discoveries of this study were conformational changes that take place upon binding of Ca /CaM in an extended conformation [49] . In addition, the substrate binding site in the DAPK1/Ca 2+ /CaM complex was occluded by Ca 2+ /CaM, suggesting that a conformational change would need to take place to fully activate DAPK1. CaMKIIs are only distantly related to DAPKs, and it seems that the interaction with Ca 2+ /CaM and the mechanism of activation of these two CaMKs are fundamentally different.
All four CaMKII isozymes were crystallized with ATP-competitive inhibitors that are relatively non-selective. However, their binding modes (see Figure S3 ) may nonetheless provide valuable chemical starting points for structure-based design of selective and potent inhibitors for the treatment of diseases. CaMKIIs have been implicated in heart failure [50] , arthritis [51] , and certain types of cancer [52] [53] [54] . The detailed comparison of the large body of structural information presented here provides the first insight into how an intact CaMKII catalytic/regulatory domain interacts with Ca 2+ /CaM. However, issues such as how catalytic domains pair together or how activation resulting from trans-phosphorylation is propagated in the holoenzyme would be best addressed by structures of full length CaMKII, an effort that is ongoing in our laboratory.
Material and Methods
Protein Expression and Purification
Expression constructs comprised the following residues of human CaMKs: CaMKId 1-333, CaMKIIa 13-301, CaMKIIb 11-302 and 358-498, CaMKIId11-335 and 334-475, CaMKIIc 5-317 and 387-527, CaMKIV 15-340, and calmodulin 1-152 Figure 3 . Details of the substrate-peptide interaction. A) Binding of the substrate sequence, including the regulatory site T287 (corresponding to T286 in the a isozyme), within the regulatory domain to the substrate binding pocket of an interacting catalytic domain. Substrate residues (green carbons) are labeled in bold and substrate positions are labeled with small Arabic numbers. The side chain of R284 forms hydrogen bonds with residues located in helix aD (E97/E100). Carbon atoms in catalytic domain residues are shown in light grey and residues are labeled in black. B) Electron density for the substrate peptide region. A region of the sigmaA-weighted electron density (2mFo-DFc) is shown contoured at 1s superposed onto the final model. were cloned into the T7 expression vector pNIC28-Bsa4 by ligation-independent cloning. Proteins were expressed in Escherichia coli BL21(DE3)R3 as fusions to a Tobacco Etch Virus (TEV)-cleavable N-terminal His 6 affinity tag. Cells were re-suspended in lysis buffer (50 mM HEPES pH 7.5 at 25uC, 0.3 M NaCl, 20 mM imidazole) in the presence of a protease inhibitor mix (Complete, EDTA-free Protease Inhibitor Cocktail, Roche Diagnostics Ltd.) and lysed using an EmulsiFlex-C5 high pressure homogenizer (Avestin) or, alternatively, by sonication at 4uC. The lysate was bound to a Ni-NTA column, extensively washed (50 mM HEPES pH 7.5, 300 mM NaCl, 20 mM imidazole) and eluted using the same buffer containing 200 mM imidazole. Proteins were dephosphorylated in vitro with the addition of 50 mM MnCl 2 and l-phosphatase overnight at 4uC. The eluted protein was pooled, concentrated and applied to either a Superdex 75 or 200 16/60 HiLoad gel filtration column equilibrated in 50 mM HEPES, pH 7.5, 300 mM NaCl, 10 mM dithiothreitol (DTT). Additional purification by ion-exchange chromatography (HiTrap Q in 50 mM Tris pH 8.8, using 0.1 to 0.7 M NaCl gradients) was used where purification was insufficient. Purity was monitored by SDS-polyacrylamide gel electrophoresis and final samples were concentrated to 10-15 mg/ml. Dephosphorylation.of CaMKIIc was inefficient, preventing TEV-cleavage due to phosphorylation of the TEV recognition motif. The alpha and gamma isozymes were crystallized in fusion with the His 6 -TEV tag.
Crystallization and X-Ray Data Collection
Crystals were obtained by the sitting drop vapour diffusion method at 4uC using conditions included in Table S1 . Inhibitors used for cocrystallization were added to the protein solutions prior to crystallization at a final concentration of 1 mM. Diffraction data were collected on beam-line X10SA at the Swiss Light Source (SLS, Paul-Scherrer Institute, Villigen, Switzerland) from crystals flashfrozen in liquid nitrogen.
Data Processing, Molecular Replacement and Refinement
Data were indexed and integrated using MOSFLM [55] and were scaled using SCALA [56] . Structures were phased by molecular replacement using PHASER [57] with the coordinates of either the C. elegans model of inactive catalytic domain [18] or the refined CaMKIIc, respectively, as search models. Refinement was carried out using REFMAC5 [58] employing appropriate geometric and non-crystallographic restraints. The models and structure factors have been deposited with PDB accession codes listed in Table S1 .
Analytical Ultracentrifugation
Sedimentation velocity experiments were carried out on an Optima XL-I Analytical Ultracentrifuge (Beckman Instruments, Palo Alto, CA) equipped with a Ti-50 rotor. Protein samples were studied at a various concentrations in 10 mM HEPES pH 7.5, containing 300 mM NaCl, 1 mM CaCl 2 and 5 mM DTT at 4uC, employing a rotor speed of 50,000 rpm. Radial absorbance scans were collected in one-minute intervals using a double-sector cell. 300 ml aliquots were loaded into the sample channels of doublechannel 12-mm centerpieces and 310 ml of buffer into the reference channels. Data were analyzed using SEDFIT [59, 60] to calculate c(s) distributions. SEDNTERP was used to normalize the obtained sedimentation coefficient values to the corresponding values in water at 20uC, s where M is the molecular weight, v is the partial specific volume, N A is Avogadro's number and s 0 20,w is the sedimentation coefficient corrected to the standard conditions of density, r 0 , and viscosity, g 0 , of water at 20.0uC, and extrapolated to infinite dilution. Sedimentation equilibrium experiments were performed at 4uC and at a number of protein concentrations. Dissociation constants, 
Isothermal Titration Calorimetry
ITC data were measured using a VP-ITC titration microcalorimeter from MicroCal, LLC (Northampton, MA). For all experiments the proteins used were dialyzed against 20 mM HEPES pH 7.5, containing 150 mM NaCl, 5 mM DTT and 1 mM CaCl 2 . Data were measured at 10uC by titrating Ca 2+ /CaM into CaMKII catalytic domains or peptides into Ca 2+ /CaM, respectively. The inhibitory peptide sequence used for titrations was ARRKLGAILTTMLATRNF, corresponding to Ca 2+ /CaM binding domain residues 296-315 in CaMKIId. Each experiment consisted of a first injection of 2 ml followed by 29 injections of 10 ml injected during 20 s and a spacing of 280 s between injections. Blank titrations (Ca 2+ /CaM into buffer) were subtracted from the titration data. Data were normalized and evaluated using ORIGIN with a single binding site model. Thermodynamic parameters were calculated using: DG = DH2TDS = 2RTlnK B , where DG, DH and DS are the changes in free energy, enthalpy and entropy of binding, respectively.
Supporting Information
Datapack S1 Standalone iSee datapack -contains the enhanced version of this article for use offline. This file can be opened using free software available for download at http://www.molsoft.com/icm_browser.html.'' Found at: doi:10.1371/journal.pbio.1000426.s001 (ICB) CaMKIId -green; CaMKIIc -orange). Structures have been superimposed using the lower lobe as a reference and differences in domain orientation of the upper lobe are evident. The tip of the Ploop is not ordered in the alpha and gamma isozymes. The main structural elements are labelled; the inhibitory helix has been highlighted in blue. B) Positioning of the helix aC in the active site of human CaMKII isozymes. Salt bridges between the conserved active site lysine (K41) and the aC glutamate (E60/61) were all between 2.7 Å and 2.8 Å , indicating an active conformation of this helix. The loop region linking the sheet b3 and aC as well as the aC N terminus showed a high degree of conformational variability, suggesting that these structural elements are quite flexible despite the constitutively active nature of the CaMKII kinase domain. C) CaMKII isozymes do not require activation segment phosphorylation for activity and the site typically phosphorylated in kinases (211 residues from APE motif) is substituted by a highly conserved /CaM binding and subsequent autophosphorylation of T287. Even when calmodulin is released from the complex following a drop in the Ca 2+ level, re-binding of the inhibitory helix is blocked (marked as a red cross) due to pT287 and a structural change in the lower kinase lobe that closes the binding site for the helix, restructures the substrate binding site (depicted as a green surface), and aligns E97 in the active site for ATP binding. As a consequence, the active state of the kinase is long-lasting and signaling pathways that lead to changes in gene transcription are activated. doi:10.1371/journal.pbio.1000426.g006 glycine residue (G173). In the absence of phosphorylation the conformational stability of the activation segment is increased by a hydrogen bond network formed by the catalytic loop R135, the backbone oxygen of L160, G173 and P172 as well as with the side chain oxygen of a highly conserved tyrosine (Y191) located in the loop linking the activation segment with helix aF. In addition, the tip of the activation segment is stabilized by a conserved cluster of hydrophobic residues (F172, I161, V164, A170) conserved in all CaMKII isozymes and most orthologues. 2 . Protein association was monitored using analytical ultracentrifugation sedimentation velocity experiments, in 10 mM HEPES buffer containing 300 mM NaCl, 1 mM CaCl 2 and 5 mM DTT, at 4uC. Distributions of species were analyzed using SEDFIT and dissociation constants were estimated from the proportions between monomer/dimer and heterodimer/ heterotetramer peaks, respectively, using K 
